Advertisement

Topics

Singulex Inc. Company Profile

16:10 EDT 26th September 2017 | BioPortfolio

Singulex develops and commercializes innovative technology solutions that enable disease understanding and management for life science researchers and clinicians. Utilizing proprietary quantitative single molecule detection technology, Singulex develops customized biomarker diagnostic systems that can detect and quantify normal and abnormal protein biomarkers in a variety of biological samples with extreme sensitivity and accuracy. Singulex is currently conducting several pilot studies with academic and molecular diagnostic partners to validate the company's commercial digital molecule detection platform, the Erenna(TM) Immunoassay System. Singulex's research and development facilities are located at the Center for Emerging Technologies in St. Louis, Missouri, and the company's commercial operations are based in Hayward, California. To learn more about Singulex, please visit us at http://www.singulex.com.


News Articles [11 Associated News Articles listed on BioPortfolio]

EU approves troponin assay from Singulex

European regulators have given Singulex the CE mark for its Sgx Clarity cTnl assay for use in quantitative measurement of tro -More- 

Singulex Expands Diagnostics Partnerships, Looks for FDA Approval of Sgx Clarity System Next Year

Singulex Release: First Ultra-Sensitive Cardiac Troponin (cTnI) Test Using Single Molecule Counting Technology Receives CE Mark

  Life Sciences Jobs   ...

Singulex Receives New, Broad Patent For Digital Detection Of Cardiac Troponin-I Or Cardiac Troponin-T For Coronary Artery Disease Rule-Out

ALAMEDA, Calif., Sept. 8, 2017 /PRNewswire/ -- Singulex announced today the granting of a significant patent for determining the absence of coronary artery disease (CAD) in a patient based upon digita...

First ultra-sensitive cardiac troponin (cTnI) test using Single Molecule Counting technology receives CE Mark

ALAMEDA, Calif., June 1, 2017 /PRNewswire/ -- Singulex, a global immunodiagnostics company pioneering ultra-sensitivity in the precision measurement of biomarkers, today announced it has applied ...

Singulex Receives New, Broad Patent For Digital Detection Of Cardiac Troponin-I Or Cardiac ...

The patent covers counting individual digital events wherein each individual digital event comprises a signal representing a single molecule of cTnI or cTnT in a Read more...

Singulex Inc Product Pipeline Analysis, 2017 Update [Updated: 20042017] Prices from USD $750

SummarySingulex Inc Singulex is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sens...

Ultra-Sensitive C. Difficile Assay In Development By Singulex Demonstrates Potential To Improve Diagnosis In Pilot Studies

NEW ORLEANS, June 5, 2017 /PRNewswire/ -- Findings presented at the American Society for Microbiology's ASM Microbe conference show that the ultra-sensitive Clostridium difficile toxin A/B assay ...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.

The utility of the levels of amyloid beta (Aβ) peptide and tau in blood for diagnosis, drug development, and assessment of clinical trials for Alzheimer's disease (AD) has not been established. The l...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Singulex Inc.

Singulex develops and commercializes innovative technology solutions that enable disease understanding and management for life science researchers and clinicians. Utilizing proprietary quantitativ...

Singulex, Inc.

Singulex, Inc. helps manage patient health risks by answering critical health questions about disease and therapeutic intervention utilizing cutting edge immunodiagnostic p...

Singulex, Inc

Singulex pioneered technology that can quantitatively detect single molecules such as proteins and metabolites in complex biological samples. Our patented technology extends the dynamic range of any i...

More Information about "Singulex Inc." on BioPortfolio

We have published hundreds of Singulex Inc. news stories on BioPortfolio along with dozens of Singulex Inc. Clinical Trials and PubMed Articles about Singulex Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Singulex Inc. Companies in our database. You can also find out about relevant Singulex Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record